Suchergebnisse - "Parniak, Michael A"

PubPharm (202)

1

HIV-1 resistance to islatravir/tenofovir combination therapy in wild-type or NRTI resistant strains of diverse HIV-1 subtypes

enthalten in: bioRxiv.org | 2023

von Cilento, M. | Wen, X. | Reeve, A. | +12

2

HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes

enthalten in: Viruses | 2023

von Cilento, M. | Wen, X. | Reeve, A. | +12

3

Development of Resistance to 4’-Ethynyl-2-Fluoro-2’-Deoxyadenosine (EFdA) by WT and Nucleoside Reverse Transcriptase Inhibitor Resistant Human Immunodeficiency Virus Type 1

enthalten in: bioRxiv.org | 2021

von Cilento, M. | Michailidis, E. | Ilina, T. | +5

4

Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Cilento, M. | Reeve, A. | Michailidis, E. | +6

5

Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation

enthalten in: Structure (London, England : 1993) | 2019

von Slack, R. | Ilina, T. | Xi, Z. | +6

6

Nanocrystal Formulation Improves Vaginal Delivery of CSIC for HIV Prevention

enthalten in: AAPS PharmSciTech | 2019

von Gong, T. | Patel, S. | Parniak, M. | +2

7

Nanocrystal Formulation Improves Vaginal Delivery of CSIC for HIV Prevention

enthalten in: AAPS PharmSciTech | 2019

von Gong, T. | Patel, S. | Parniak, M. | +2

8

Nanocrystal Formulation Improves Vaginal Delivery of CSIC for HIV Prevention

enthalten in: AAPS PharmSciTech | 2019

von Gong, T. | Patel, S. | Parniak, M. | +2

9

Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H : Tolerance of a nonflexible linker

enthalten in: European journal of medicinal chemistry | 2019

von Tang, J. | Do, H. | Huber, A. | +7

10

6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity

enthalten in: European journal of medicinal chemistry | 2018

von Wang, L. | Tang, J. | Huber, A. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]